Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhao Feng

Showing results (551-560 of 567) with videos related to

Pageof 57
Sort By:
Nature|March 1, 2019
Managing nitrogen to restore water quality in ChinaChaoQing Yu, Xiao Huang, Han Chen, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of an Kai Chu, Zhao-Feng Bi, Wei-Jin Huang, et al.
The Lancet Regional Health. Western Pacific|September 8, 2025
Immunogenicity comparison of an <i>Escherichia coli</i>-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18-26 years: three-year follow-up data from a randomised clinical trialGuo-Hua Zhong, Zhao-Feng Bi, Kai Chu, et al.
Neuron|April 10, 2025
Single-neuron projectome reveals organization of somatosensory ascending pathways in the mouse brainWen-Qun Ding, Wei Song, Xiaoxue Shi, et al.
The Lancet. Infectious Diseases|July 20, 2023
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trialFeng-Cai Zhu, Guo-Hua Zhong, Wei-Jin Huang, et al.
Nature|July 3, 2025
A mouse brain stereotaxic topographic atlas with isotropic 1-μm resolutionZhao Feng, Xiangning Li, Yue Luo, et al.
Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trialHong-Xing Pan, Zhao-Feng Bi, Yu-Lin Jing, et al.
World Journal of Pediatrics : WJP|October 7, 2021
Expert consensus on COVID-19 vaccination in childrenYue-Jie Zheng, Xiao-Chuan Wang, Lu-Zhao Feng, et al.
World Journal of Pediatrics : WJP|September 29, 2021
Global Pediatric Pulmonology Alliance (GPPA) proposal for COVID-19 vaccination in childrenLance E Rodewald, Kun-Ling Shen, Yong-Hong Yang, et al.
Pageof 57

Showing results (551-560 of 567) with videos related to

Sort By:
Pageof 57
Nature|March 1, 2019
Managing nitrogen to restore water quality in ChinaChaoQing Yu, Xiao Huang, Han Chen, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of an Kai Chu, Zhao-Feng Bi, Wei-Jin Huang, et al.
The Lancet Regional Health. Western Pacific|September 8, 2025
Immunogenicity comparison of an <i>Escherichia coli</i>-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18-26 years: three-year follow-up data from a randomised clinical trialGuo-Hua Zhong, Zhao-Feng Bi, Kai Chu, et al.
Neuron|April 10, 2025
Single-neuron projectome reveals organization of somatosensory ascending pathways in the mouse brainWen-Qun Ding, Wei Song, Xiaoxue Shi, et al.
The Lancet. Infectious Diseases|July 20, 2023
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trialFeng-Cai Zhu, Guo-Hua Zhong, Wei-Jin Huang, et al.
Nature|July 3, 2025
A mouse brain stereotaxic topographic atlas with isotropic 1-μm resolutionZhao Feng, Xiangning Li, Yue Luo, et al.
Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trialHong-Xing Pan, Zhao-Feng Bi, Yu-Lin Jing, et al.
World Journal of Pediatrics : WJP|October 7, 2021
Expert consensus on COVID-19 vaccination in childrenYue-Jie Zheng, Xiao-Chuan Wang, Lu-Zhao Feng, et al.
World Journal of Pediatrics : WJP|September 29, 2021
Global Pediatric Pulmonology Alliance (GPPA) proposal for COVID-19 vaccination in childrenLance E Rodewald, Kun-Ling Shen, Yong-Hong Yang, et al.
Pageof 57